Amdocs (DOX) Tops Q1 EPS by 7c

Amdocs (NASDAQ: DOX) reported Q1 EPS of $0.88, $0.07 better than the analyst estimate of $0.81. Revenue for the quarter came in at $906 million versus the consensus estimate of $909.28 million.

Amdocs sees Q2 2015 EPS of $0.78-$0.84, versus the consensus of $0.84.

For earnings history and earnings-related data on Amdocs (DOX) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance